Ubs Group Ag Bausch Health Companies Inc. Put Options Transaction History

Ubs Group Ag

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 13, 2024	BUY	$7.77 - $10.61 $287,490 - $392,570	37,000 New	37,000 $392,000
Q1 2022 May 16, 2022	SELL	$21.6 - $27.79 $8.43 Million - $10.9 Million	-390,500 Reduced 92.98%	29,500 $674,000
Q3 2019 Nov 14, 2019	BUY	$20.88 - $25.66 $1.85 Million - $2.27 Million	88,600 Added 26.74%	420,000 $9.18 Million
Q2 2019 Aug 14, 2019	SELL	$20.52 - $26.45 $471,960 - $608,350	-23,000 Reduced 6.49%	331,400 $8.36 Million
Q1 2019 May 14, 2019	SELL	$20.23 - $26.29 $19.9 Million - $25.9 Million	-983,700 Reduced 73.51%	354,400 $8.75 Million
Q4 2018 Feb 14, 2019	BUY	$17.64 - $28.32 $3.93 Million - $6.31 Million	222,800 Added 19.98%	1,338,100 $24.7 Million
Q3 2018 Nov 14, 2018	BUY	$20.64 - $25.67 $23 Million - $28.6 Million	1,115,300 New	1,115,300 $28.6 Million

254

254M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.83B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.